Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0NAJBC
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
mAb2DesignB-SLAE
|
|||||
| Synonyms |
mAb2DesignB-SLAE
Click to Show/Hide
|
|||||
| Organization |
Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.; Freie Universität Berlin; Technische Universität Berlin; Hamburg University of Applied Sciences.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
1.77
|
|||||
| Structure |
|
|||||
| Antibody Name |
mAb2DesignB
|
Antibody Info | Antigen Name |
Undisclosed
|
||
| Payload Name |
SLAuristatin E derivate
|
Payload Info | ||||
| Therapeutic Target |
Microtubule (MT)
|
Target Info | ||||
| Linker Name |
DBCO-C4-PEG3-VC-PABC
|
Linker Info | ||||
| Conjugate Type |
DBCO-Azide Click Chemistry Conjugation
|
|||||